Thalidomide induces clinical remission and mucosal healing in adults with active Crohn’s disease: a prospective open-label study

摘要

Background:Thalidomide is effective in inducing and maintaining clinical remission in children and adolescents with refractory Crohn’s disease (CD). However, little is known about the efficacy and safety of thalidomide for adult patients with CD.